Reaktionsgleichung
[NH2:1][C:2]1[CH:9]=[CH:8][C:7]([C:10]2[CH:15]=[C:14]([Cl:16])[CH:13]=[C:12]([Cl:17])[CH:11]=2)=[C:6]([Cl:18])[C:3]=1[C:4]#[N:5].Cl.Cl[C:21]([NH2:23])=[NH:22]>COCCOCCOC>[NH2:23][C:21]1[N:22]=[C:4]([NH2:5])[C:3]2[C:2](=[CH:9][CH:8]=[C:7]([C:10]3[CH:11]=[C:12]([Cl:17])[CH:13]=[C:14]([Cl:16])[CH:15]=3)[C:6]=2[Cl:18])[N:1]=1Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
This compound was prepared in a manner analogous to that of Step E of Example 1, using 1.5 grams (0.005 mole) of 2-amino-6-chloro-5-(3,5-dichlorophenyl)benzonitrile and 0.7 gram (0.006 mole) of chloroformamidine hydrochloride in 10 mL of 2-methoxyethyl ether. The solid was recrystallized from methanol, yielding 0.5 gram of 2,4-diamino-5-chloro-6-(3,5-dichlorophenyl)quinazoline. The NMR spectrum was consistent with the proposed structure; however, methanol was present in the sample.
Aufarbeitung
- customThis compound was prepared in a manner analogous to that of Step E of Example 1
- customThe solid was recrystallized from methanol
Quellen und Nachweise
- ORD-Eintrag
- ord-e145f74ce3f8467a8c98b2a6c584ddca
- Quelldatensatz
- uspto-grants-1999_02
- Patentnummer
- US05874579
Verknüpfte Notizen
Wird geladen…